Nachrichten zur GSK PLC Aktie

GSKs vaccine receives positive European Medicines Agency opinion

GSK PLCs (LSE:GSK, NYSE:GSK) respiratory syncytial virus vaccine, Arexvy, has received a positive opinion from the European Medicines Agencys Committee...…

Merz will europäische Pharmaindustrie stärken

DRESDEN (dpa-AFX) - Der CDU-Bundesvorsitzende Friedrich Merz will die Wettbewerbsfähigkeit der europäischen Pharmaindustrie stärken. Es brauche…

GSK downgraded by UBS over vaccine concerns, Zantac litigation

UBS analysts have downgraded GSK PLC (LSE:GSK, NYSE:GSK) from a buy to neutral rating, citing uncertainties surrounding its vaccine portfolio and...…

ANALYSE-FLASH: UBS senkt GSK auf 'Neutral' - Ziel runter auf 1580 Pence

ZÜRICH (dpa-AFX) - Die Schweizer Großbank UBS hat GSK von "Buy" auf "Neutral" abgestuft und…

Global Herpes Treatment Market Size To Worth USD 1.87 Billion By 2033 | CAGR Of 4.28%

The Global Herpes Treatment Market Size was Valued at USD 1.23 Billion in 2023 and the Worldwide Herpes Treatment Market…

GSK takes full control of flu vaccine programme in €1.45bn deal

GSK PLC (LSE:GSK, NYSE:GSK) said it will take effective control of a collaboration to create new mRNA vaccines for influenza and…

GSK and Moderna slide on RSV vaccine CDC updates

GSK PLC (LSE:GSK, NYSE:GSK) shares fell 6% after US authorities recommended restrictions on doses of any respiratory syncytial virus (RSV) vaccine.…

GSK and Moderna RSV vaccine sell-off is overdone, say analysts

After GSK PLC (LSE:GSK, NYSE:GSK) shares fell sharply on the back of US authorities restricting doses of respiratory syncytial virus (RSV)…

GSK plunges as US restricts RSV vaccine

GSK PLC (LSE:GSK, NYSE:GSK) shares plunged close to 7% following a ruling in the US that is likely to restrict…

GSK plummets as US restricts RSV vaccine

GSK PLC (LSE:GSK, NYSE:GSK) is attempting to drive the FTSE 100 lower after it plunged close to 7% following a…

GSK plunges as US restricts RSV vaccine

GSK PLC (LSE:GSK, NYSE:GSK) shares plunged close to 7% following a ruling in the US that is likely to restrict…

GSK 100% backs London listing, says boss

GSK PLC (LSE:GSK, NYSE:GSK) has issued its support to the flagging London market, stating that it is “unequivocally, 100 per cent…

GSK still appealing despite US legal setback says broker

GSK PLC (LSE:GSK, NYSE:GSK) is still appealing - even in the wake of a significant legal setback, according to regional…

GSK appeals Delaware Zantac ruling

GSK PLC (LSE:GSK, NYSE:GSK) and other pharmaceutical companies asked a Delaware court to allow an appeal of a ruling permitting…

GSK RSV jab receives label expansion from US regulator

GSK PLC (LSE:GSK, NYSE:GSK) has confirmed that the US Food & Drug Administration has approved Arexvy for preventing respiratory syncytial…

GSK: Still reasons to be cheerful rather than fearful after nightmare Monday

What was supposed to be a stellar day for GSK PLC (LSE:GSK, NYSE:GSK) at the annual American Society of Clinical…

GSK-Aktie stürzt nach Gerichtsurteil ab - Aktienanalyse

Wien (www.aktiencheck.de) - GSK-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), nimmt die…

GSK: Zantac-Klagen - Belastungen in Milliardenhöhe? Aktienanalyse

Kulmbach (www.aktiencheck.de) - GSK-Aktienanalyse von "Der Aktionär": Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt die Aktie von GSK plc (ISIN: GB00BN7SWP63,…

GSK: Zantac litigation obscures the positives, says leading investment bank

Deutsche Bank has maintained its "buy" rating on GSK PLC (LSE:GSK, NYSE:GSK) despite the recent setback in the Zantac litigation as…

GSK: Zantac litigation obscures the positives, says leading investment bank

Deutsche Bank has maintained its "buy" rating on GSK PLC (LSE:GSK, NYSE:GSK) despite the recent setback in the Zantac litigation as…

GSK shares plunge after US judge rules Zantac cases can go to trial

GSK PLC (LSE:GSK, NYSE:GSK) lost over £6 billion in market value after court judge in the US state of Delaware allowed more…

GSK shares plunge after US judge rules Zantac cases can go to trial

GSK PLC (LSE:GSK, NYSE:GSK) lost over £6 billion in market value after court judge in the US state of Delaware allowed more…

GSK to appeal US judges Zantac ruling, shares plunge

GSK PLC (LSE:GSK, NYSE:GSK) lost over £6 billion in market value after court judge in the US state of Delaware allowed more…

GSK shares plunge after US judge rules Zantac cases can go ahead

GSK PLC (LSE:GSK, NYSE:GSK) lost over £6 billion in market value after court judge in the US state of Delaware allowed more…

GSK to appeal US judges Zantac ruling

GSK PLC (LSE:GSK, NYSE:GSK) says it disagrees with a decision by a court judge in the US state of Delaware who…

GSK plc: Long-Term Cash Cow

…

GSK found not guilty in Zantac trial

British pharmaceuticals big cap GSK PLC (LSE:GSK, NYSE:GSK) has won a high-stake personal injury case in the state of Illinois,…

GSK found not guilty in Zantac trial

British pharmaceuticals big cap GSK PLC (LSE:GSK, NYSE:GSK) has won a high-stake personal injury case in the state of Illinois,…

GSK: Zantac settlement could reach $2bn, says investment bank

GSK PLC (LSE:GSK, NYSE:GSK) may face a settlement of up to $2 billion to resolve thousands of lawsuits related to…

GSK: Moderate Bewertung trotz Kursanstieg - Aktienanalyse

Wien (www.aktiencheck.de) - GSK-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI), stuft die…

GSK confirms Haleon exit for total of £3.9 billion

GSK PLC (LSE:GSK, NYSE:GSK) confirmed it has raised a total of £3.9 billion through the exit of its stake in…

GSK confirms exit of Haleon stake for £3.9 billion

GSK PLC (LSE:GSK, NYSE:GSK) confirmed it has raised a total of £3.9 billion through the exit of its stake in…

GSK plc (GSK) Q1 2024 Earnings Call Transcript

…

GSK beginning to alleviate long-held concerns, say analysts

GSK PLC (LSE:GSK, NYSE:GSK) is approaching 18-month highs after the pharma groups boss Emma Walmsley raised the full-year outlook on the…

Pharmahersteller GSK erhöht Gewinnziel für 2024

LONDON (dpa-AFX) - Der Pharmakonzern GSK ist besser als erwartet in das neue Jahr gestartet.…

GSK Q1 beats consensus and FY numbers upgraded after vaccines boost

GSK PLC (LSE:GSK, NYSE:GSK) has confirmed what recent prescription data hinted at: Its vaccines business is firing on all cylinders.…

The Global Market for HPV Associated Disorders, 2018-2023 and 2024-2033, Featuring Profiles of Leading Players AstraZeneca, Roche, Biocon, GlaxoSmithKline, and Merck & Co

Dublin, April 19, 2024 (GLOBE NEWSWIRE) -- The "HPV Associated Disorders Global Market Report 2024" report has been…

Global CAR T-Cell Therapy Market Size To Worth USD 21.92 Billion By 2033 | CAGR of 17.72%

The Global CAR T-Cell Therapy Market Size was Valued at USD 4.29 Billion in 2023 and the Worldwide CAR T-Cell…

GSK Follows Rivals, to Cap Out-of-Pocket Inhaler Cost in US

GSK plc (GSK) plans to lower the prices of its entire inhaled respiratory products to $35 per month in the…

ANALYSE-FLASH: Jefferies belässt GSK auf 'Buy' - Ziel 1950 Pence

NEW YORK (dpa-AFX Broker) - Das Analysehaus Jefferies hat die Einstufung für GSK auf "Buy"…

GSK plc (GSK) TD Cowen 44th Annual Health Care Conference (Transcript)

…

GSK: Has Blenreps blockbuster status been restored?

GSK PLC (LSE:GSK, NYSE:GSK) cancer discovery Blenreps blockbuster potential has been reawakened, according to Shore Capital. The broker was commenting...…

GSK boss sees pay jump 51% in 2023

GSK PLC (LSE:GSK, NYSE:GSK) boss Emma Walmsley saw her overall pay rise 51% to around £13 million in 2023 after…

GSK settles another Zantac lawsuit in California

GSK PLC (LSE:GSK, NYSE:GSK) has confidentially settled a lawsuit in California that claimed its now-discontinued heartburn medication, Zantac, caused...…

GSK settles another California lawsuit

GSK PLC (LSE:GSK, NYSE:GSK) has confidentially settled a lawsuit in California that claimed its now-discontinued heartburn medication, Zantac, caused...…

Antisense and RNAi Therapeutics Market Size & Share Envisaged To Reach USD 18.43 Billion By 2032, at 17.8% CAGR Growth: Polaris Market Research

The global Antisense and RNAi Therapeutics Market size and share is currently valued at USD 4.34 billion in 2023. It…

GSK plc: An Undervalued Vaccine Behemoth That Is Resuming Growth; Buy

…

GSK: American investment bank goes positive on the stock for the first time in seven years. Heres why

The healthcare team at Citi has turned positive on GSK PLC (LSE:GSK, NYSE:GSK) for the first time in seven years.…

Gummy Market to surpass $51 Bn by 2032, Says Global Market Insights Inc.

Major gummy market participants include Nestle SA, Bayer AG, Church & Dwight Co. Inc, Procter & Gamble, Unilever PLC (OLLY),…

GSK agrees another Zantac settlement in California

GSK PLC (LSE:GSK, NYSE:GSK) has reached a confidential settlement regarding a lawsuit in California, which accused its discontinued heartburn medication,...…